Jordan Schaefer, MD, MSc, FACP, FAHA
Clinical Associate Professor of Internal Medicine
Medical School
Office:
Michigan Medicine
Internal Medicine - Hematology/Oncology
1500 E. Medical Center Drive, C366
Ann Arbor, Michigan 48109
Internal Medicine - Hematology/Oncology
1500 E. Medical Center Drive, C366
Ann Arbor, Michigan 48109
Email:
[email protected]
Phone:
Available to mentor
Jordan Schaefer, MD, MSc, FACP, FAHA
Clinical Associate Professor
Manage Your Profile
Center Memberships
-
Center MemberInstitute for Healthcare Policy and Innovation
-
Center MemberRogel Cancer Center
Recent Publications
-
Mahmoud A, Muradashvili T, Schaefer JK. Research and Practice in Thrombosis and Haemostasis, 2026 Oct 2; 107004Journal ArticleFactor XI and XIa Inhibitors: Defining Their Role and Considering Their Implementation
DOI:10.1016/j.rpth.2026.107004 -
Awuah D, Zestos S, Errickson J, Kong X, Ali M, Giuliano C, Haymart B, Kaatz S, DeCamillo D, Ryan N, Sood S, Froehlich JB, Barnes GD, Schaefer JK. Res Pract Thromb Haemost, 2026 Jul; 10 (5): 106825Journal ArticleComparison of monthly bleeding rates after direct oral anticoagulant initiation for venous thromboembolism and atrial fibrillation.
DOI:10.1016/j.rpth.2026.106825 PMID: PMC13448006 -
Martin KA, Wilkinson K, Sparks A, Roetker NS, Gergi M, Adrianzen Herrera D, Schaefer JK, Li A, Gangaraju R, Sprague BL, Holmes C, Zakai NA. J Thromb Haemost, 2026 Jun 11;Journal ArticleDevelopment and Validation of a Risk Assessment Model for Hospital-Acquired Venous Thrombosis in Medical Inpatients with Cancer.
DOI:10.1016/j.jtha.2026.06.007 PMID: 42276273 -
Gan Y, Liang W, Liu C, Yalavarthi S, Warnock M, Sabb K, Sarosh C, Schaefer JK, Tambralli A, Madison JA, Emal CD, Tsou PS, Shi H, Zuo Y, Lawrence DA, Knight JS. Journal of Autoimmunity, 2026 Jun 1; 161:Journal ArticleEndothelial cell-derived plasminogen activator inhibitor-1 potentiates thrombosis in antiphospholipid syndrome
DOI:10.1016/j.jaut.2026.103563 -
Schaefer J, Wu Z, Jiang L, Polk A, Gouveia-Pisano J, DeLor B, Dettloff R, Dai F, Banuri N, Escobar J, Medico,PharmD,BCPS CJ, Sood S. Arteriosclerosis Thrombosis and Vascular Biology, 2026 Jul 30; 46 (Suppl_1):Journal ArticleAbstract Fri147: Provider Attitudes and Perspectives on How Social Determinants of Health Influence Anticoagulant Prescribing for Venous Thromboembolic Disease in the United States
DOI:10.1161/atvb.46.suppl_1.fri147 -
Sinha A, Errickson J, Gu X, Ali MA, Giuliano C, Haymart B, Kaatz S, DeCamillo D, Ryan N, Sood SL, Froehlich JB, Barnes GD, Schaefer JK. JAMA Network Open, 2026 May 1; 9 (5): e2612617Journal ArticleLong-Term Outcomes of a Multicenter Aspirin Deprescribing Intervention
DOI:10.1001/jamanetworkopen.2026.12617 PMID: 42133317 -
Chiang CJ, Bria KE, Chrysafi P, Falvello V, Sanfilippo KM, Schaefer JK, Bauer K, Patell R, Baumann Kreuziger L, Freese RL, Gutierrez Bernal A. Crit Care Med, 2026 Apr 23;Journal ArticleEffects of Early Versus Delayed Mechanical Thrombectomy on Outcomes in Intermediate-Risk Acute Pulmonary Embolism.
DOI:10.1097/CCM.0000000000007130 PMID: 42023946 -
Falvello V, Barnes GD, Bradshaw M, Errickson J, Gu X, Li A, Ali MA, Haymart B, Kaatz S, Froehlich JB, Cheng B, Thompson MP, Schaefer JK. TH Open, 2026 Mar 26; 10 (CP):Journal ArticleCost Avoidance Associated with Aspirin De-Prescribing Among Patients Receiving Warfarin
DOI:10.1055/a-2833-3348
Featured News & Stories
Health Lab
Social, financial barriers linked to reduced treatment for dangerous blood clots
People who experience social and financial challenges are less likely to receive certain anticoagulant prescriptions for potentially deadly blood clots, according to a study.
Health Lab
Nearly 1 in 6 older adults take aspirin despite no history of heart disease
Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease, despite stricter guidelines. For some patients, the benefit of aspirin may not outweigh the risk of bleeding.
